alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 21.1**

**NATIONAL TECHNICAL SYSTEMS, INC.**

**LIST OF SUBSIDIARIES**

NTS, TECHNICAL SYSTEMS, A CALIFORNIA CORP.(FORMERLYNATIONAL TECHNICAL SYSTEMS, A CALIFORNIA CORP.)

ACTON ENVIRONMENTAL TESTING CORPORATION, A MASSACHUSETTS CORP.

APPROVED ENGINEERING TESTING LABORATORIES, INC., A CALIFORNIA CORP.

ETCR INC., A CALIFORNIA CORP.

XXCAL, INC., A CALIFORNIA CORP.

NATIONAL QUALITY ASSURANCE, INC., A MASSACHUSETTS CORP. (50% OWNED)

NTS EUROPE, GmbH

AETL TESTING, INC. dba NTS CALGARY

PHASE SEVEN LABORATORIES, A CALIFORNIA CORP.

----
#### The People of the State of New York, Respondent, v Hansel J. Gernstl, Appellant.

[852 NYS2d 857]

Present-Scudder, P.J., Martoche, Smith, Green and Gorski, JJ.
[Federal Register Volume 82, Number 163 (Thursday, August 24, 2017)]
[Notices]
[Page 40151]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17965]



[[Page 40151]]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 2343-086]


PE Hydro Generation, LLC; Notice of Availability of Draft 
Environmental Assessment

    In accordance with the National Environmental Policy Act of 1969 
and the Federal Energy Regulatory Commission's (Commission) 
regulations, 18 CFR part 380 (Order No. 486, 52 FR 47879), the Office 
of Energy Projects has reviewed the application for a new license for 
the Millville Hydroelectric Project, located on the Shenandoah River, 
near the town of Harpers Ferry in Jefferson County, West Virginia, and 
has prepared a draft Environmental Assessment (draft EA) for the 
project. The project does not occupy federal land.
    In the draft EA, Commission staff analyze the potential 
environmental effects of relicensing the project and conclude that 
continued project operation under a new license, with appropriate 
measures, would not constitute a major federal action significantly 
affecting the quality of the human environment.
    A copy of the draft EA is available for review at the Commission in 
the Public Reference Room or may be viewed on the Commission's Web site 
at www.ferc.gov using the eLibrary link. Enter the docket number, 
excluding the last three digits, in the docket number field to access 
the document. For assistance, contact FERC Online Support at 
<a href="/cdn-cgi/l/email-protection#387e7d6a7b77565451565d6b4d4848574a4c785e5d4a5b165f574e"><span class="__cf_email__" data-cfemail="a8eeedfaebe7c6c4c1c6cdfbddd8d8c7dadce8cecddacb86cfc7de">[email protected]</span></a> or toll-free number at 1-866-208-3676, or 
for TTY, 202-502-8659.
    You may also register online at www.ferc.gov/docs-filing/esubscription.asp to be notified via email of new filings and issuances 
related to this or other pending projects. For assistance, contact FERC 
Online Support.
    For further information, please contact Michael Spencer by 
telephone at (202) 502-6093 or by email at <a href="/cdn-cgi/l/email-protection#0d60646e656c6861237e7d68636e687f4d6b687f6e236a627b"><span class="__cf_email__" data-cfemail="ee83878d868f8b82c09d9e8b808d8b9cae888b9c8dc0898198">[email protected]</span></a>.

    Dated: August 16, 2017.
Kimberly D. Bose,
Secretary.
[FR Doc. 2017-17965 Filed 8-23-17; 8:45 am]
 BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 57 Introduced in Senate (IS)]

114th CONGRESS
  1st Session
                                 S. 57

  To amend the Food and Nutrition Act of 2008 to prevent the illegal 
 trafficking of supplemental nutrition assistance program benefits by 
requiring all program beneficiaries to show valid photo identification 
              when purchasing items with program benefits.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 7, 2015

  Mr. Vitter introduced the following bill; which was read twice and 
   referred to the Committee on Agriculture, Nutrition, and Forestry

_______________________________________________________________________

                                 A BILL

 
  To amend the Food and Nutrition Act of 2008 to prevent the illegal 
 trafficking of supplemental nutrition assistance program benefits by 
requiring all program beneficiaries to show valid photo identification 
              when purchasing items with program benefits.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Food Stamp Fraud Prevention and 
Accountability Act''.

SEC. 2. PHOTO IDENTIFICATION REQUIREMENT.

    (a) Disqualification for Using Another EBT Card.--Section 6 of the 
Food and Nutrition Act of 2008 (7 U.S.C. 2015) is amended by adding at 
the end the following:
    ``(t) Disqualification for Using Another EBT Card.--Subject to any 
requirements established by the Secretary, any person who has been 
found by a State or Federal court or administrative agency in a hearing 
under subsection (b) to have intentionally used an EBT card that was 
issued to a household of which the person is not a member shall be 
ineligible for benefits under this Act.''.
    (b) Optional Photographic Identification.--Section 7(h)(9) of the 
Food and Nutrition Act of 2008 (7 U.S.C. 2016(h)(9)) is amended by 
adding at the end the following:
                    ``(C) Listed beneficiaries.--
                            ``(i) In general.--If a State agency elects 
                        not to require that an EBT card contain a 
                        photograph described in subparagraph (A), the 
                        State agency shall list on the EBT card the 
                        name of each member of the household who may 
                        use the card.
                            ``(ii) Photographic identification 
                        required.--A member of a household with an EBT 
                        card issued by a State agency described in 
                        clause (i) shall be required to show 
                        photographic identification at the point of 
                        sale when using the EBT card.''.
                                 <all>
```
No. 1139.

#### Landreth *v.*Wabash Railroad Co.

May 27, 1946.

*Royal W. Irwin*for petitioner.

*Elmer W. Freytag*for respondent.

*Lee Pressman*and *Frank Donner*filed a brief for the United Railroad Workers, as *amicus curiae,*in support of the petition.

Petition for writ of certiorari to the Circuit Court of Appeals for the Seventh Circuit denied.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          JAN-31-1998
<PERIOD-END>                               JAN-31-1998
<CASH>                                           2,101
<SECURITIES>                                         0
<RECEIVABLES>                                   15,546
<ALLOWANCES>                                       666
<INVENTORY>                                      1,860
<CURRENT-ASSETS>                                20,230
<PP&E>                                          48,509
<DEPRECIATION>                                  29,527
<TOTAL-ASSETS>                                  40,719
<CURRENT-LIABILITIES>                            6,554
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        11,069
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    40,719
<SALES>                                         56,114
<TOTAL-REVENUES>                                56,114
<CGS>                                           40,863
<TOTAL-COSTS>                                   40,863
<OTHER-EXPENSES>                                 9,173
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,135
<INCOME-PRETAX>                                  4,941
<INCOME-TAX>                                     1,968
<INCOME-CONTINUING>                              2,973
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,947
<EPS-PRIMARY>                                     0.43
<EPS-DILUTED>                                     0.42
        

</TABLE>
EXHIBIT 32.1



                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


      In connection with the Quarterly Report of IntegraMed  America,  Inc. (the
      "Company")  on Form 10-Q for the period ended  September 30, 2007 as filed
      with the  Securities  and  Exchange  Commission  on the date  hereof  (the
      "Report"), I, Jay Higham, Chief Executive Officer of the Company, certify,
      pursuant to 18 U.S.C.  /s/ 1350, as adopted pursuant to section 906 of the
      Sarbanes-Oxley Act of 2002, that to my knowledge:

          1.  The Report fully complies with the  requirements  of Section 13(a)
              or 15(d) of the Securities Exchange Act of 1934; and

          2.  The information  contained in the Report fairly  presents,  in all
              material  respects,   the  financial   condition  and  results  of
              operations of the Company.



                                /s/Jay Higham
                                   --------------------------
                                   Jay Higham
                                   Chief Executive Officer
                                   November 14, 2007
Summary of Compensation Arrangements with Named Executive Officers and Directors



 Exhibit 10.16 
 SUMMARY OF COMPENSATION ARRANGEMENTS 
 WITH NAMED EXECUTIVE OFFICERS AND DIRECTORS 

(EFFECTIVE MARCH 1, 2009) 
 Named Executive
Officers 
 The following summarizes the current cash compensation and benefits received by the Company’s Chief Executive Officer,
its Chief Financial Officer and its next three most highly compensated executive officers for the fiscal year ended December 31, 2008 (the “Named Executive Officers”). The following is intended to be a summary of existing oral, at
will arrangements, and in no way is intended to provide any additional rights to any of the Named Executive Officers. 
 None of the
Company’s executive officers has a written employment agreement with the Company. The executive officers of the Company serve at the discretion of the Board of Directors. The Compensation Committee of the Board (the “Committee”)
reviews and recommends to the Board the compensation that is paid to the Company’s executive officers, including the salaries of the Named Executive Officers. The salaries of the Named Executive Officers as of March 1, 2009 are as follows:

  

					
	 Name and Position
	  	Salary	 
	 J. Boyd Douglas
	  	$	500,000	 
	 President, CEO and Director
	  			
		
	 Darrell G. West
	  	$	300,000	 
	 Vice President – Finance and CFO
	  			
		
	 Michael S. Jones
	  	$	400,000	 
	 Executive Vice President and COO
	  			
		
	 Thomas W. Peterson
	  	$	325,000	 
	 Senior Vice President – Clinical Informatics
	  			
		
	 Victor S. Schneider
	  	$	250,000	(1)
	 Senior Vice President – Corporate and Business Development
	  			

  

	 (1)
	 In addition to this base salary, Mr. Schneider is eligible
to receive sales commissions. Such commissions are included each year as part of this individuals’ salary for purposes of determining their status as a Named Executive Officer. 


 The Named Executive Officers are eligible to receive discretionary bonuses. The Named Executive Officers are also eligible to participate in the
Company’s the 2002 Stock Option Plan and the 2005 Restricted Stock Plan, as well as the Company’s regular benefit plans and programs. All executive benefit plans and forms of agreements are filed as exhibits to the Company’s Exchange
Act filings. Information regarding these plans and agreements, as well as compensation earned by the Named Executive Officers during fiscal 2008, will be included in the Company’s 2009 Proxy Statement. 
 Directors 
 Current director compensation arrangements
provide that non-employee directors, other than members of the Audit Committee, will receive an annual retainer of $10,000. Each director who is a member of the Audit Committee receives an annual retainer of $15,000. Each non-employee director also
receives an attendance fee of $2,000 for each regular quarterly meeting of the Board of Directors. Directors are also reimbursed for their expenses incurred in attending any meeting of directors.
Exhibit 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies, in his capacity as an officer of The Finish Line, Inc. (the Company), for purposes of 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:



| |  |  | The Quarterly Report of the Company on Form 10-Q for the thirteen weeks ended June 2, 2007 fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934 (15 U.S.C. 78); and
| | - |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | The information contained in such report fairly presents, in all material respects, the financial condition and results of operation of the Company.
| | - |  | ----------------------------------------------------------------------------------------------------------------------------------------------------

Dated: June 28, 2007



|                                                                         
|-------------------------------------------------------------------------
|/s/ Alan H. Cohen                                                        
|Alan H. Cohen                                                            
|Chairman and Chief Executive Officer                                     
|                                                                         
|/s/ Kevin S. Wampler                                                     
|Kevin S. Wampler                                                         
|Executive Vice-President, Chief Financial Officer and Assistant Secretary
[Federal Register Volume 82, Number 162 (Wednesday, August 23, 2017)]
[Notices]
[Page 40024]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17916]


=======================================================================
-----------------------------------------------------------------------

LEGAL SERVICES CORPORATION


Sunshine Act Meeting: Finance Committee. Postponed

AGENCY: Legal Services Corporation.

ACTION: Postponement notice.

-----------------------------------------------------------------------

SUMMARY: On August 15, 2017, the Legal Services Corporation (LSC) 
published a notice in the Federal Register (82 FR 38712) titled 
``Finance Committee Telephonic Meeting on August 21, 2017 at 12:00 
p.m., EDT.'' The meeting has been postponed, and the agenda will be 
covered at a later date. This document announces the postponement of 
the meeting.

CHANGES IN THE MEETING:  Postponed.

DATES: This postponement is effective August 18, 2017.

FOR FURTHER INFORMATION CONTACT: Katherine Ward, Executive Assistant to 
the Vice President for Legal Affairs and General Counsel, Legal 
Services Corporation, 3333 K Street NW., Washington, DC 20007; (202) 
295-1500; <a href="/cdn-cgi/l/email-protection#402b37213224002c33236e272f36"><span class="__cf_email__" data-cfemail="acc7dbcddec8ecc0dfcf82cbc3da">[email protected]</span></a>.

    Dated: August 18, 2017.
Katherine Ward,
Executive Assistant to the Vice President for Legal Affairs and General 
Counsel.
[FR Doc. 2017-17916 Filed 8-21-17; 11:15 am]
BILLING CODE 7050-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 82, Number 161 (Tuesday, August 22, 2017)]
[Notices]
[Page 39878]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17656]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Genes and Genetics of Diseases.
    Date: September 12, 2017.
    Time: 11:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Richard A. Currie, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 1108, MSC 7890, Bethesda, MD 
20892, (301) 435-1219, <a href="/cdn-cgi/l/email-protection#a4c7d1d6d6cdc1d6cde4c7d7d68acacdcc8ac3cbd2"><span class="__cf_email__" data-cfemail="6f0c1a1d1d060a1d062f0c1c1d4101060741080019">[email protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-15-276: Turkey-U.S. Program for Affordable Medical 
Technologies.
    Date: September 12, 2017.
    Time: 1:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 
20892, (301) 435-3504, <a href="/cdn-cgi/l/email-protection#55213a213d3621153626277b3b3c3d7b323a23"><span class="__cf_email__" data-cfemail="72061d061a1106321101005c1c1b1a5c151d04">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 16, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-17656 Filed 8-21-17; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### Jorge AVILA-CERVANTES, Petitioner, v. Michael B. MUKASEY, Attorney General, Respondent.

No. 06-73422.

United States Court of Appeals, Ninth Circuit.

Submitted Dec. 20, 2007.*

Filed Dec. 28, 2007.

Michael Franquinha, Law Office of Michael Franquinha, Phoenix, AZ, for Petitioner.

Ronald E. Lefevre, Chief Counsel, Office of the District Counsel, Department of Homeland Security, San Francisco, CA, Aviva L. Poczter, Esq., Nehal H. Kamani, U.S. Department of Justice, Civil Div./Office of Immigration Lit., Washington, DC, CAS-District Counsel, San Diego, CA, for Respondent.

Before: GOODWIN, WALLACE, and HAWKINS, Circuit Judges.

*

 The panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Jorge Avila-Cervantes, a native and citizen of Mexico, petitions for review of the Board of Immigration Appeals’ (“BIA”) order denying his motion to reopen removal proceedings. We have jurisdiction pursuant to 8 U.S.C. § 1252. We review for abuse of discretion the denial of a motion to reopen, *Iturribarria v. INS,*321 F.3d 889, 894 (9th Cir.2003), and we deny the petition for review.

*766The BIA did not abuse its discretion by denying the motion to reopen, where the BIA considered the evidence of Avila-Cervantes’ U.S. citizen son’s new, undiagnosed medical condition and acted within its broad discretion in determining that the evidence was insufficient to warrant reopening. *See Singh v. INS,*295 F.8d 1037, 1039 (9th Cir.2002) (BIA’s denial of a motion to reopen shall be reversed only if it is “arbitrary, irrational or contrary to law”).

PETITION FOR REVIEW DENIED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.

HAWKINS, Circuit Judge,

dissenting.

I respectfully dissent. When Petitioner moved to re-open, the Department of Homeland Security did oppose a grant. Petitioner should be given an opportunity to present his new evidence.
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Aerosonic Corporation. (the Company) on Form
10-K for the year ended January 31, 2009, as filed with the Securities and Exchange Commission (the Report), I, Douglas J. Hillman, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as
adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the
requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in
the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                   |  |  |  |     |  |                        |  |                                                         
|------------------ |  |  |  | --- |  | ---------------------- |  | --------------------------------------------------------
|Dated: May 1, 2009 |  |  |  | By: |  | /s/ DOUGLAS J. HILLMAN
|                   |  |  |  |     |  |                        |  | Douglas J. Hillman President and Chief Executive Officer

This certification accompanies this Report on Form 10-K pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. A signed original of this written statement
required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. 24-0012

STATE OF MONTANA,

Plaintiff and Appellee,

v.

MICHAEL ROSS TROMBLEY,

Defendant and Appellant.

GRANT

Pursuant to authority granted under Mont. R. App. P. 26(1), the 

Appellant is given an extension of time until April 10, 2024 to prepare, 

file, and serve the Appellant’s opening brief.

Electronically signed by:

Bowen Greenwood

Clerk of the Supreme Court

March 5 2024

03/05/2024

Case Number: DA 24-0012